JP2017522384A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017522384A5 JP2017522384A5 JP2017524097A JP2017524097A JP2017522384A5 JP 2017522384 A5 JP2017522384 A5 JP 2017522384A5 JP 2017524097 A JP2017524097 A JP 2017524097A JP 2017524097 A JP2017524097 A JP 2017524097A JP 2017522384 A5 JP2017522384 A5 JP 2017522384A5
- Authority
- JP
- Japan
- Prior art keywords
- hours
- cancer
- protein
- igg
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1413240.1A GB201413240D0 (en) | 2014-07-25 | 2014-07-25 | Method |
| GB1413240.1 | 2014-07-25 | ||
| PCT/EP2015/065895 WO2016012285A2 (en) | 2014-07-25 | 2015-07-10 | Method |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017522384A JP2017522384A (ja) | 2017-08-10 |
| JP2017522384A5 true JP2017522384A5 (https=) | 2018-08-23 |
| JP6708641B2 JP6708641B2 (ja) | 2020-06-10 |
Family
ID=51587261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017524097A Active JP6708641B2 (ja) | 2014-07-25 | 2015-07-10 | 方法 |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US10973889B2 (https=) |
| EP (2) | EP3171891B1 (https=) |
| JP (1) | JP6708641B2 (https=) |
| KR (2) | KR20230119267A (https=) |
| CN (2) | CN114949187A (https=) |
| AU (1) | AU2015294125B2 (https=) |
| BR (1) | BR112017001420A2 (https=) |
| CA (1) | CA2955704A1 (https=) |
| CL (1) | CL2017000191A1 (https=) |
| CO (1) | CO2017000571A2 (https=) |
| DK (1) | DK3171891T3 (https=) |
| EA (1) | EA039169B1 (https=) |
| ES (1) | ES3054696T3 (https=) |
| FI (1) | FI3171891T3 (https=) |
| GB (1) | GB201413240D0 (https=) |
| HR (1) | HRP20251560T1 (https=) |
| IL (1) | IL249981B (https=) |
| LT (1) | LT3171891T (https=) |
| MX (1) | MX2017001138A (https=) |
| MY (1) | MY196858A (https=) |
| PL (1) | PL3171891T3 (https=) |
| PT (1) | PT3171891T (https=) |
| RS (1) | RS67520B1 (https=) |
| SG (1) | SG11201700172WA (https=) |
| SI (1) | SI3171891T1 (https=) |
| WO (1) | WO2016012285A2 (https=) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201413240D0 (en) * | 2014-07-25 | 2014-09-10 | Hansa Medical Ab | Method |
| GB201502305D0 (en) | 2015-02-12 | 2015-04-01 | Hansa Medical Ab | Protein |
| GB201502306D0 (en) | 2015-02-12 | 2015-04-01 | Hansa Medical Ab | Protein |
| US10858422B2 (en) | 2016-05-31 | 2020-12-08 | Abcentra, Llc | Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody |
| US10434141B2 (en) | 2016-05-31 | 2019-10-08 | Abcentra, Llc | Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody |
| US20210228738A1 (en) | 2017-07-17 | 2021-07-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins |
| CN113518783A (zh) | 2018-07-20 | 2021-10-19 | 动量制药公司 | FcRn抗体组合物 |
| WO2020232247A1 (en) | 2019-05-14 | 2020-11-19 | Provention Bio, Inc. | Methods and compositions for preventing type 1 diabetes |
| CN114450397A (zh) * | 2019-08-01 | 2022-05-06 | 纪念斯隆-凯特琳癌症中心 | 用于改善免疫疗法的细胞及其用途 |
| EP4007605A4 (en) * | 2019-08-01 | 2023-08-16 | Momenta Pharmaceuticals, Inc. | ANTI-FCRN ANTIBODIES AND METHODS OF USE THEREOF |
| KR20220133969A (ko) | 2020-01-28 | 2022-10-05 | 프리라인 테라퓨틱스 리미티드 | 바이러스 벡터에 대한 중화 항체 역가를 결정하기 위한 개선된 분석법 |
| GB202002072D0 (en) * | 2020-02-14 | 2020-04-01 | Hansa Biopharma AB | immunoglobulin detection and associated therapies |
| GB202003129D0 (en) * | 2020-03-04 | 2020-04-15 | Hansa Biopharma AB | Conditioning regimen for transplant of stem cells |
| GB202007431D0 (en) * | 2020-05-19 | 2020-07-01 | Hansa Biopharma AB | Cysteine protease |
| GB202007434D0 (en) * | 2020-05-19 | 2020-07-01 | Hansa Biopharma AB | Methods |
| IL298999A (en) | 2020-06-11 | 2023-02-01 | Provention Bio Inc | Methods and compositions for the prevention of type 1 diabetes |
| CN120078887A (zh) * | 2020-09-21 | 2025-06-03 | 上海宝济药业股份有限公司 | 一种药物组合及其应用 |
| CA3195177A1 (en) | 2020-10-07 | 2022-04-14 | Asklepios Biopharmaceutical, Inc. | Therapeutic adeno-associated virus delivery of fukutin related protein (fkrp) for treating dystroglycanopathy disorders including limb girdle 2i (lgmd2i) |
| WO2022221529A1 (en) | 2021-04-16 | 2022-10-20 | Asklepios Biopharmaceutical, Inc. | Rational polyploid aav virions that cross the blood brain barrier and elicit reduced humoral response |
| EP4079848A1 (en) | 2021-04-22 | 2022-10-26 | Genovis Ab | Immunoglobulin cleaving enzyme |
| JP2024520444A (ja) | 2021-05-24 | 2024-05-24 | プロヴェンション・バイオ・インコーポレイテッド | １型糖尿病を治療するための方法 |
| US20250325640A1 (en) | 2021-11-15 | 2025-10-23 | Hansa Biopharma AB | Methods for enhancing adoptive cell transfer immunotherapies |
| KR20240155358A (ko) | 2022-03-17 | 2024-10-28 | 아스트라제네카 아일랜드 리미티드 | 개선된 IgG-분해 효소 및 이의 사용 방법 |
| AU2023383441A1 (en) | 2022-11-18 | 2025-06-05 | Seismic Therapeutic, Inc. | Fc fusion molecules and uses thereof |
| CN116087528A (zh) * | 2022-12-27 | 2023-05-09 | 华中科技大学同济医学院附属同济医院 | 一种sqtsm1蛋白在卵巢早衰的应用 |
| WO2024148276A1 (en) | 2023-01-06 | 2024-07-11 | Seismic Therapeutic, Inc. | Protease variants and uses thereof |
| WO2025248469A1 (en) * | 2024-05-28 | 2025-12-04 | Biohaven Therapeutics Ltd. | TREATMENT OF IgG-RELATED DISEASES |
| WO2025256978A1 (en) | 2024-06-13 | 2025-12-18 | Bayer Aktiengesellschaft | Variants of igm and igg cleaving enzymes |
| WO2025256977A1 (en) | 2024-06-13 | 2025-12-18 | Bayer Aktiengesellschaft | Novel igm and igg cleaving enzymes |
| GB202413764D0 (en) | 2024-09-18 | 2024-10-30 | Genovis Ab | Immunoglobulin proteases and their uses |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| JPH0612624B2 (ja) * | 1984-06-20 | 1994-02-16 | 株式会社日立製作所 | 半導体集積回路装置 |
| DE69723888T2 (de) * | 1996-05-09 | 2004-05-27 | The General Hospital Corp., Boston | Gemischter Chimerismus und Toleranz |
| PL1901773T3 (pl) * | 2005-06-09 | 2012-09-28 | Hansa Medical Ab | Zastosowanie proteinazy IDES (Z S. Pyogenes) do leczenia chorób autoimmunologicznych oraz odrzutów przeszczepu |
| GB0511769D0 (en) * | 2005-06-09 | 2005-07-20 | Hansa Medical Ab | Treatment |
| GB2427360A (en) * | 2005-06-22 | 2006-12-27 | Complex Biosystems Gmbh | Aliphatic prodrug linker |
| GB0624874D0 (en) * | 2006-12-13 | 2007-01-24 | Hansa Medical Ab | Treatment |
| DK2190984T3 (da) | 2007-09-14 | 2013-12-02 | Genovis Ab | Fremgangsmåder og kits til oprensning og påvisning af glycosyleret IgG |
| GB201115841D0 (en) * | 2011-09-13 | 2011-10-26 | Genovis Ab | Protein and method |
| GB201201314D0 (en) * | 2012-01-26 | 2012-03-07 | Isis Innovation | Composition |
| TWI626491B (zh) * | 2012-12-10 | 2018-06-11 | 布萊恩荷登視覺協會 | 用於視力校正之具有一或多個多正焦區域之眼用光學透鏡 |
| GB201413240D0 (en) * | 2014-07-25 | 2014-09-10 | Hansa Medical Ab | Method |
| GB201502305D0 (en) * | 2015-02-12 | 2015-04-01 | Hansa Medical Ab | Protein |
| GB201502306D0 (en) * | 2015-02-12 | 2015-04-01 | Hansa Medical Ab | Protein |
| GB202007434D0 (en) * | 2020-05-19 | 2020-07-01 | Hansa Biopharma AB | Methods |
-
2014
- 2014-07-25 GB GBGB1413240.1A patent/GB201413240D0/en not_active Ceased
-
2015
- 2015-07-10 LT LTEPPCT/EP2015/065895T patent/LT3171891T/lt unknown
- 2015-07-10 SI SI201532086T patent/SI3171891T1/sl unknown
- 2015-07-10 US US15/328,879 patent/US10973889B2/en active Active
- 2015-07-10 SG SG11201700172WA patent/SG11201700172WA/en unknown
- 2015-07-10 CA CA2955704A patent/CA2955704A1/en active Pending
- 2015-07-10 CN CN202210234712.4A patent/CN114949187A/zh active Pending
- 2015-07-10 JP JP2017524097A patent/JP6708641B2/ja active Active
- 2015-07-10 WO PCT/EP2015/065895 patent/WO2016012285A2/en not_active Ceased
- 2015-07-10 EP EP15756845.2A patent/EP3171891B1/en active Active
- 2015-07-10 BR BR112017001420A patent/BR112017001420A2/pt not_active Application Discontinuation
- 2015-07-10 FI FIEP15756845.2T patent/FI3171891T3/fi active
- 2015-07-10 ES ES15756845T patent/ES3054696T3/es active Active
- 2015-07-10 KR KR1020237026683A patent/KR20230119267A/ko not_active Ceased
- 2015-07-10 EP EP25199052.9A patent/EP4663755A3/en active Pending
- 2015-07-10 IL IL249981A patent/IL249981B/en unknown
- 2015-07-10 PL PL15756845.2T patent/PL3171891T3/pl unknown
- 2015-07-10 CN CN201580049441.3A patent/CN106714834A/zh active Pending
- 2015-07-10 HR HRP20251560TT patent/HRP20251560T1/hr unknown
- 2015-07-10 KR KR1020177005456A patent/KR102565244B1/ko active Active
- 2015-07-10 MY MYPI2017000280A patent/MY196858A/en unknown
- 2015-07-10 AU AU2015294125A patent/AU2015294125B2/en active Active
- 2015-07-10 EA EA201790192A patent/EA039169B1/ru unknown
- 2015-07-10 PT PT157568452T patent/PT3171891T/pt unknown
- 2015-07-10 DK DK15756845.2T patent/DK3171891T3/da active
- 2015-07-10 RS RS20251260A patent/RS67520B1/sr unknown
- 2015-07-10 MX MX2017001138A patent/MX2017001138A/es unknown
-
2017
- 2017-01-24 CO CONC2017/0000571A patent/CO2017000571A2/es unknown
- 2017-01-25 CL CL2017000191A patent/CL2017000191A1/es unknown
-
2021
- 2021-03-03 US US17/191,634 patent/US12397044B2/en active Active
-
2025
- 2025-07-07 US US19/261,759 patent/US20260000739A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017522384A5 (https=) | ||
| US20230391820A1 (en) | Hydrophobic interaction protein chromatography under no-salt conditions | |
| KR102524594B1 (ko) | 시스테인 프로테아제 | |
| KR102524613B1 (ko) | 시스테인 프로테아제 | |
| JP2022191210A5 (https=) | ||
| US20250230186A1 (en) | Stabilised Protein Solutions | |
| WO2019040671A1 (en) | METHODS OF PURIFYING ANTIBODIES HAVING REDUCED AGGREGATES OF HIGH MOLECULAR WEIGHT | |
| JP2023535842A5 (https=) | ||
| US12577275B2 (en) | Hydrophobic interaction chromatography carrier and protein purification method | |
| JP7744561B2 (ja) | 自動インジェクターアセンブリ | |
| RU2832029C1 (ru) | Автоинъекторное устройство для подачи лекарственных препаратов | |
| JP7833407B2 (ja) | 薬剤を送達するための自動インジェクターデバイス | |
| NZ743923B2 (en) | Chimeric proteins and methods of immunotherapy | |
| WO2024057095A1 (en) | Mutant protease | |
| NZ743923A (en) | Chimeric proteins and methods of immunotherapy | |
| HK40062718A (en) | Hydrophobic interaction protein chromatography under no-salt conditions | |
| US20200147070A1 (en) | Inducing phospholipidosis for enhancing therapeutic efficacy | |
| NZ728265B2 (en) | Methods to enhance organ transplant and antibody therapies | |
| CN104955479A (zh) | 高温死端抗体过滤 | |
| WO2018132874A1 (en) | Method of preventing an immune response with alpha- 1 anti-trypsin | |
| NZ728265A (en) | Methods to enhance organ transplant and antibody therapies |